Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Schramm

Showing results (171-180 of 228) with videos related to

Pageof 23
Sort By:
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 19, 2023
Surface Chemistry and Specific Surface Area Rule the Efficiency of Gold Nanoparticle Sensitizers in Proton TherapyJacob Johny, Charlotte E R van Halteren, Fatih-Can Cakir, et al.
Oncotarget|November 16, 2013
BET bromodomain protein inhibition is a therapeutic option for medulloblastomaAnton Henssen, Theresa Thor, Andrea Odersky, et al.
Craniomaxillofacial Trauma & Reconstruction|November 17, 2022
The Global Impact of COVID-19 on Craniomaxillofacial Surgeons: A Follow-Up Survey After One YearTevfik Cicek, Justin van der Tas, Thomas Dodson, et al.
Neuro-Oncology|May 18, 2012
Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomasAnnette Künkele, Katleen De Preter, Lukas Heukamp, et al.
Acta Neuropathologica Communications|November 21, 2013
The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastomaKristian W Pajtler, Christina Weingarten, Theresa Thor, et al.
Scientific Reports|April 30, 2020
N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastomaBritta Tjaden, Katharina Baum, Viktoria Marquardt, et al.
Genome Biology|September 23, 2006
Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genesKatleen De Preter, Jo Vandesompele, Pierre Heimann, et al.
International Journal of Cancer|February 13, 2013
MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1AKristina Althoff, Anneleen Beckers, Andrea Odersky, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 2020
HDAC inhibition synergizes with ALK inhibitors to overcome resistance in a novel ALK mutated lung adenocarcinoma modelPaul Stockhammer, Cassandra Su Lyn Ho, Luca Hegedus, et al.
Cancer Letters|January 7, 2019
Synergistic activity of BET inhibitor MK-8628 and PLK inhibitor Volasertib in preclinical models of medulloblastomaYoujia Han, Sven Lindner, Yi Bei, et al.
Pageof 23

Showing results (171-180 of 228) with videos related to

Sort By:
Pageof 23
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 19, 2023
Surface Chemistry and Specific Surface Area Rule the Efficiency of Gold Nanoparticle Sensitizers in Proton TherapyJacob Johny, Charlotte E R van Halteren, Fatih-Can Cakir, et al.
Oncotarget|November 16, 2013
BET bromodomain protein inhibition is a therapeutic option for medulloblastomaAnton Henssen, Theresa Thor, Andrea Odersky, et al.
Craniomaxillofacial Trauma & Reconstruction|November 17, 2022
The Global Impact of COVID-19 on Craniomaxillofacial Surgeons: A Follow-Up Survey After One YearTevfik Cicek, Justin van der Tas, Thomas Dodson, et al.
Neuro-Oncology|May 18, 2012
Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomasAnnette Künkele, Katleen De Preter, Lukas Heukamp, et al.
Acta Neuropathologica Communications|November 21, 2013
The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastomaKristian W Pajtler, Christina Weingarten, Theresa Thor, et al.
Scientific Reports|April 30, 2020
N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastomaBritta Tjaden, Katharina Baum, Viktoria Marquardt, et al.
Genome Biology|September 23, 2006
Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genesKatleen De Preter, Jo Vandesompele, Pierre Heimann, et al.
International Journal of Cancer|February 13, 2013
MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1AKristina Althoff, Anneleen Beckers, Andrea Odersky, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 2020
HDAC inhibition synergizes with ALK inhibitors to overcome resistance in a novel ALK mutated lung adenocarcinoma modelPaul Stockhammer, Cassandra Su Lyn Ho, Luca Hegedus, et al.
Cancer Letters|January 7, 2019
Synergistic activity of BET inhibitor MK-8628 and PLK inhibitor Volasertib in preclinical models of medulloblastomaYoujia Han, Sven Lindner, Yi Bei, et al.
Pageof 23